March 4, 2020
The Ministry of Health, Labor and Welfare (MHLW) on February 28 issued a notification informing that Novartis Pharma’s long-acting somatostatin analog Sandostatin for SC Injection (ocreotide) became eligible for health coverage on the same day for the treatment of hypoglycemia...read more